Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: WS06.6 Effect of lumacaftor/ivacaftor on lung clearance index and exercise capacity among patients aged over 12 years with cystic fibrosis homozygous for F508del-CFTR, Journal of Cystic Fibrosis, June 2018, Elsevier,
DOI: 10.1016/s1569-1993(18)30154-1.
You can read the full text:
Contributors
The following have contributed to this page
